Skip to main content
Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.50
-0.36 (-2.02%)
Apr 24, 2025, 4:08 PM HKT

Sinopharm Group Revenue

In the year 2024, Sinopharm Group had annual revenue of 584.51B CNY, down -2.02%. Sinopharm Group had revenue of 144.89B in the quarter ending December 31, 2024, a decrease of -3.82%.

Revenue
584.51B CNY
Revenue Growth
-2.02%
P/S Ratio
0.09
Revenue / Employee
5.40M CNY
Employees
108,217
Market Cap
54.61B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024584.51B-12.06B-2.02%
Dec 31, 2023596.57B44.42B8.05%
Dec 31, 2022552.15B31.10B5.97%
Dec 31, 2021521.05B64.64B14.16%
Dec 31, 2020456.41B31.14B7.32%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeiGene 29.60B
Hansoh Pharmaceutical Group Company 13.05B
JD Health International 61.89B
WuXi Biologics 19.87B
Innovent Biologics 10.03B
Akeso 2.26B
Alibaba Health Information Technology 31.39B
CSPC Pharmaceutical Group 30.87B
Revenue Rankings

Sinopharm Group News

More News